Headquartered in Dublin, Ireland, global pharmaceutical company Allergan, has just agreed to acquire private eye care biotechnology company ForSight VISION5 for $95 million. The deal will also include the launch milestone payment for the biotech’s lead product, which is inserted on the surface of the eye and allows for the extended release of glaucoma medication, … Continue reading “Allergan (AGN) Will Buy This Company For $95M”
